Satoshi Setoguchi

Direttore/Membro del Consiglio presso ASTENA HOLDINGS CO., LTD.

Patrimonio netto: 212 385 $ in data 31/05/2024

52 anni

Health Technology

Retail Trade

Profilo

Satoshi Setoguchi is currently working as the President, CEO, Chief Operating Officer & Director at Iwaki & Co., Ltd.
He is also serving as the Director & Managing Executive Officer at Astena Holdings Co., Ltd.
since 2020 and as a Director at Apros Corp.
since 2015.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
ASTENA HOLDINGS CO.,LTD. 0.17%	30/11/2023	69 100 ( 0.17% )	212 385 $	31/05/2024

Posizioni attive di Satoshi Setoguchi

Società	Posizione	Inizio
ASTENA HOLDINGS CO., LTD.	Direttore/Membro del Consiglio	01/02/2019
Apros Corp.	Direttore/Membro del Consiglio	01/12/2015
Iwaki & Co., Ltd. Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi.	Amministratore Delegato	-

Tutte le posizioni attive di Satoshi Setoguchi

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Satoshi Setoguchi

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ASTENA HOLDINGS CO., LTD.	Health Technology

Aziende private	2
Apros Corp.
Iwaki & Co., Ltd. Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi.	Retail Trade